B

Biosergen AB
STO:BIOSGN

Watchlist Manager
Biosergen AB
STO:BIOSGN
Watchlist
Price: 39.52 SEK -3.61% Market Closed
Market Cap: 92.9m SEK

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of BIOSGN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIOSGN Intrinsic Value
Not Available
B
Base Case Scenario
Compare BIOSGN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BIOSGN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biosergen AB

Current Assets 25.5m
Cash & Short-Term Investments 22.7m
Receivables 2.8m
Current Liabilities 5.3m
Other Current Liabilities 5.3m
Efficiency

Free Cash Flow Analysis
Biosergen AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biosergen AB

Revenue
0 SEK
Operating Expenses
-30.7m SEK
Operating Income
-30.7m SEK
Other Expenses
98k SEK
Net Income
-30.6m SEK
Fundamental Scores

BIOSGN Profitability Score
Profitability Due Diligence

Biosergen AB's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
38/100
Profitability
Score

Biosergen AB's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

BIOSGN Solvency Score
Solvency Due Diligence

Biosergen AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Biosergen AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOSGN Price Targets Summary
Biosergen AB

Wall Street analysts forecast BIOSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOSGN is 153 SEK with a low forecast of 151.5 SEK and a high forecast of 157.5 SEK.

Lowest
Price Target
151.5 SEK
283% Upside
Average
Price Target
153 SEK
287% Upside
Highest
Price Target
157.5 SEK
299% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Biosergen AB
does not pay dividends
Shareholder Yield

Current shareholder yield for BIOSGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y